Skip to main content
logo
Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.91
+0.79 (5.59%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Crescent Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Market Capitalization
638232-
Market Cap Growth
170.67%--
Enterprise Value
468104-
Last Close Price
14.9111.86-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
PS Ratio
53.7021.38-
PB Ratio
3.131.14-
P/TBV Ratio
4.011.17-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
EV/Sales Ratio
39.389.62-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Debt / Equity Ratio
0.010.01-3.26
Net Debt / Equity Ratio
-1.04-1.04-0.24
Net Debt / EBITDA Ratio
1.001.39-
Net Debt / FCF Ratio
2.312.92-0.11
Asset Turnover
-0.08-
Quick Ratio
9.266.413.62
Current Ratio
9.666.563.62
Return on Equity (ROE)
--160.75%-
Return on Assets (ROA)
--69.15%-
Return on Capital Employed (ROCE)
-103.70%-74.70%-264.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Earnings Yield
-25.87%-66.40%-
FCF Yield
-11.54%-31.25%-
Buyback Yield / Dilution
--1465.00%-
SEC Filings: 10-K · 10-Q